PDCD1 and neoplasm: They identified a specific group of CD73hi macrophages in the samples of glioblastoma patients who underwent anti-PD-1 therapy using scRNA-seq. The expression of immunosuppressive genes in the CD73hi cells was enhanced, and the CD73hi cells reduced T cell infiltration in the tumor tissues and reduced the sensitivity of immunotherapy in the patients.